Wenzel, Mike;
von Hardenberg, Jost;
Welte, Maria N.;
Doryumu, Samuel;
Hoeh, Benedikt;
Wittler, Clarissa;
Höfner, Thomas;
Kriegmair, Maximilian C.;
Michel, Maurice S.;
Chun, Felix KH.;
Herrmann, Jonas;
Mandel, Philipp;
Westhoff, Niklas
Monoprophylaxis With Cephalosporins for Transrectal Prostate Biopsy After the Fluoroquinolone-Era: A Multi-Institutional Comparison of Severe Infectious Complications
Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
Medientyp:
E-Artikel
Titel:
Monoprophylaxis With Cephalosporins for Transrectal Prostate Biopsy After the Fluoroquinolone-Era: A Multi-Institutional Comparison of Severe Infectious Complications
Beteiligte:
Wenzel, Mike;
von Hardenberg, Jost;
Welte, Maria N.;
Doryumu, Samuel;
Hoeh, Benedikt;
Wittler, Clarissa;
Höfner, Thomas;
Kriegmair, Maximilian C.;
Michel, Maurice S.;
Chun, Felix KH.;
Herrmann, Jonas;
Mandel, Philipp;
Westhoff, Niklas
Erschienen:
Frontiers Media SA, 2021
Erschienen in:
Frontiers in Oncology, 11 (2021)
Sprache:
Nicht zu entscheiden
DOI:
10.3389/fonc.2021.684144
ISSN:
2234-943X
Entstehung:
Anmerkungen:
Beschreibung:
BackgroundTo compare severe infectious complication rates after transrectal prostate biopsies between cephalosporins and fluoroquinolones for antibiotic monoprophylaxis.Material and MethodsIn the multi-institutional cohort, between November 2014 and July 2020 patients received either cefotaxime (single dose intravenously), cefpodoxime (multiple doses orally) or fluoroquinolones (multiple-doses orally or single dose intravenously) for transrectal prostate biopsy prophylaxis. Data were prospectively acquired and retrospectively analyzed. Severe infectious complications were evaluated within 30 days after biopsy. Logistic regression models predicted biopsy-related infectious complications according to antibiotic prophylaxis, application type and patient- and procedure-related risk factors.ResultsOf 793 patients, 132 (16.6%) received a single dose of intravenous cefotaxime and were compared to 119 (15%) who received multiple doses of oral cefpodoxime and 542 (68.3%) who received fluoroquinolones as monoprophylaxis. The overall incidence of severe infectious complications was 1.0% (n=8). No significant differences were observed between the three compared groups (0.8% vs. 0.8% vs. 1.1%, p=0.9). The overall rate of urosepsis was 0.3% and did not significantly differ between the three compared groups as well.ConclusionMonoprophylaxis with third generation cephalosporins was efficient in preventing severe infectious complications after prostate biopsy. Single intravenous dose of cefotaxime and multiday regimen of oral cefpodoxime showed a low incidence of infectious complications <1%. No differences were observed in comparison to fluoroquinolones.